Worm N
Versicherungsmedizin. 1995 Aug 1;47(4):116-22.
Three saturated fatty acids (C 12:0, C 14:0, C 16:0) raise LDL cholesterol but also HDL cholesterol levels. Replacement of these fatty acids by monounsaturated or omega-6 polyunsaturated fatty acids will lower LDL cholesterol as well as HDL cholesterol levels. Fat modified diets therefore may not improve the ratio of LDL to HDL cholesterol. Linoleic acid enhances sterol excretion but also increases cholesterol synthesis so that total body cholesterol is not diminished. Moreover various potentially adverse effects have been reported for n-6 polyunsaturated fatty acids. Recent cross-cultural ecologic studies as well as all major within-population cohort studies have not been able to find an association between cholesterol raising saturated fatty acids of animal fat and risk of Coronary Heart Disease (CDH). On the other hand several cohort and case control studies have shown an increase in CHD risk with increasing consumption of partly hydrogenated vegetable margarines. Meta-analyses of controlled intervention studies reveal that cholesterol lowering diets have failed to lower risk of CHD or total mortality. Yet controlled studies implementing a high level of antioxidants in the diet or increasing the n-3 unsaturated fatty acid content have been able to lower CHD and total mortality. It is time to discuss whether the concept of dietary intervention with the "classic" cholesterol lowering diet is still justified.
三种饱和脂肪酸(C12:0、C14:0、C16:0)会升高低密度脂蛋白胆固醇水平,但也会提高高密度脂蛋白胆固醇水平。用单不饱和脂肪酸或ω-6多不饱和脂肪酸替代这些脂肪酸会降低低密度脂蛋白胆固醇以及高密度脂蛋白胆固醇水平。因此,脂肪改良饮食可能无法改善低密度脂蛋白与高密度脂蛋白胆固醇的比例。亚油酸可促进固醇排泄,但也会增加胆固醇合成,因此总体内胆固醇并未减少。此外,已有报道称ω-6多不饱和脂肪酸存在各种潜在的不良反应。近期的跨文化生态学研究以及所有主要的人群队列研究均未能发现动物脂肪中升高胆固醇的饱和脂肪酸与冠心病(CDH)风险之间存在关联。另一方面,几项队列研究和病例对照研究表明,随着部分氢化植物人造黄油消费量的增加,冠心病风险会升高。对照干预研究的荟萃分析显示,降低胆固醇的饮食未能降低冠心病风险或总死亡率。然而,在饮食中实施高水平抗氧化剂或增加ω-3不饱和脂肪酸含量的对照研究已能够降低冠心病和总死亡率。现在是时候讨论采用“经典”降低胆固醇饮食进行饮食干预的概念是否仍然合理了。